Daily Dividend Update: ABT, ZTS, EQR, PM, AMAT
Zoetis Dividend Announcement: Zoetis has declared a quarterly dividend of $0.53 per share for Q1 2026, marking a 6% increase from 2025, payable on March 3, 2026, to shareholders of record by January 20, 2026.
Equity Residential Dividend Declaration: Equity Residential's Board of Trustees announced a quarterly dividend of $0.6925 per common share for Q4 2025, to be paid on January 16, 2026, to shareholders of record by January 2, 2026.
Philip Morris International Dividend: Philip Morris International declared a quarterly dividend of $1.47 per common share, payable on January 14, 2026, to shareholders of record as of December 26, 2025, with the ex-dividend date also on December 26, 2025.
Applied Materials Dividend Approval: Applied Materials' Board of Directors approved a quarterly cash dividend of $0.46 per share, payable on March 12, 2026, to shareholders of record by February 19, 2026.
Get Free Real-Time Notifications for Any Stock
Analyst Views on ABT
About ABT
About the author

Abbott's Stock Drops Following Earnings Report as CEO Purchases $2 Million in Shares.
- Stock Performance: Abbott Laboratories experienced its largest stock drop in over 20 years following the release of its fourth-quarter earnings report.
- CEO's Confidence: Despite the significant decline in share value, the company's chief executive remains optimistic about the stock's future.

Abbott Shares Snap Six-Day Losing Streak with 1.2% Gain
- Stock Rebound: Abbott shares closed 1.2% higher at $108.77 on Monday after six consecutive days of losses, indicating a short-term sentiment rebound despite an overall weak trend.
- Revenue Underperformance: The company reported lower-than-expected revenue for Q4 2025, particularly in its Nutrition segment, leading to a 10% drop in stock price last Thursday, reflecting market concerns about its growth potential.
- Analyst Ratings: According to Seeking Alpha's Quant Rating, Abbott holds a Hold rating with a score of 3.06, indicating strong profitability prospects (A+) but weak growth factors (D-), which may affect investor confidence.
- Executive Buy: Abbott's Chairman and CEO Robert Ford recently purchased 18,800 shares worth over $2 million, signaling executive confidence in the company's future, which may attract more investor interest.









